Trial Profile

Formoterol-beclomethasone in patients with bronchiectasis: a randomized, double-blind, placebo-controlled trial (Forza study)

Status: Discontinued

Phase of Trial: Phase III

Latest Information Update: 09 Nov 2023

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Beclometasone/formoterol (Primary)
Indications Bronchiectasis
Focus Therapeutic Use
Acronyms FORZA

Most Recent Events

13 Sep 2023 Results presented at the 33rd Annual Congress of the European Respiratory Society
28 Feb 2023 Status changed from recruiting to discontinued.
24 Mar 2022 Planned End Date changed from 1 Dec 2019 to 1 Jun 2023.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com